Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q4 2017 Earnings

13MarExpected

Q1 2017

Q2 2017

Q3 2017

Q4 2017

-9.75

-6.66

-3.56

-0.47

Details

Expected EPS

-0.53

Actual EPS

-9.75

Surprise EPS

-9.22

Surprise Percent

+1,739.62%

Description

Spyre Therapeutics (SYRE) has reported earnings of -9.75 per share for Q4 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.